Skip to content
The Nexus
DossierENTITY

$400bn tie-up

Coverage of $400bn tie-up in the Nexus archive.

Earliest in view: Aug 11 · 04:00 UTCMost recent: Aug 11 · 04:00 UTC
Co-mentioned in this coverage
AstraZenecaorganization1Bristol Myersorganization1United Statesplace1mergertopic1pharma megadealstopic1
Recent coverage
  • BUSINESSAug 11 · 04:00 UTCFINANCIAL TIMES WORLD
    How AstraZeneca’s $400bn tie-up with US rival Bristol Myers unravelled

    The article details how a potential $400bn tie-up and merger between AstraZeneca and its US rival, Bristol Myers, ultimately unravelled. Had this mega-deal proceeded, it would have represented a notable return to major pharma megadeals.

$400bn tie-up · Dossier · The Nexus